GlassScriptPhysician profile
Anita Chait
NPI 1629143888
$3,464.07
in general payments reported to CMS, 2019-2025
17 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $646 · 2021: $510 · 2022: $533 · 2023: $488 · 2024: $120 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.00 |
| Education | $145.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $1,800.00 | 2019-2022 | |
| Abbvie INC. | $490.04 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $144.00 | 2021-2025 | |
| Myovant Sciences INC. | $138.98 | 2021-2022 | |
| Biotissue Holdings INC. | $138.58 | 2025 | |
| Astellas Pharma US INC | $135.04 | 2023-2024 | Veozah |
| Agile Therapeutics, INC. | $129.87 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $98.19 | 2020-2025 | Slynd, Nuvessa |
| Pfizer INC. | $71.29 | 2023 | |
| Evofem Biosciences, INC. | $68.97 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $67.07 | 2023-2025 | Myfembree |
| Millicent US INC | $60.71 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Lupin INC. | $58.57 | 2019-2021 | |
| Mycovia Pharmaceuticals, INC. | $18.87 | 2023 | Vivjoa |
| Coopersurgical, INC. | $16.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $14.70 | 2025 | |
| Avion Pharmaceuticals | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anita Chait listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.